Results 11 to 20 of about 6,321,039 (371)

A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice

open access: yesAnnals of Clinical and Translational Neurology, Volume 9, Issue 12, Page 1985-1998, December 2022., 2022
Abstract Objectives Peripheral neuropathy is a relevant dose‐limiting adverse event that can affect up to 90% of oncologic patients with colorectal cancer receiving oxaliplatin treatment. The severity of neurotoxicity often leads to dose reduction or even premature cessation of chemotherapy.
Aina Calls   +9 more
wiley   +1 more source

PD-1 blockade inhibits osteoclast formation and murine bone cancer pain.

open access: yesJournal of Clinical Investigation, 2020
Emerging immune therapy, such as with the anti-programmed cell death-1 (anti-PD-1) monoclonal antibody nivolumab, has shown efficacy in tumor suppression.
Kaiyuan Wang   +9 more
semanticscholar   +1 more source

The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer

open access: yesBMC Health Services Research, 2020
Background Canada legalized cannabis use for medical purposes in 1999. Legalization of cannabis for recreational purposes in October 2018 offered the opportunity to assess the impact of recreational legalization on cancer patients’ patterns of use to ...
Philippa Hawley   +2 more
doaj   +1 more source

The Modified WHO Analgesic Ladder: Is It Appropriate for Chronic Non-Cancer Pain?

open access: yesJournal of Pain Research, 2020
Introduction From 1986, the World Health Organization (WHO) analgesic ladder has been used as the simple and valuable pain-relieving guidance in the pharmaceutical pain management, however, with the development of medical history, notions about pain ...
Juan Yang   +4 more
semanticscholar   +1 more source

Arytenoid dislocation after uneventful endotracheal intubation: a case report [PDF]

open access: yesKorean Journal of Anesthesiology, 2016
Arytenoid dislocation is an unusual complication of endotracheal intubation. We reported a case of a 48-year-old female with arytenoid dislocation after uneventful endotracheal intubation, which was successfully treated with arytenoid reduction.
Tak Kyu Oh   +4 more
doaj   +1 more source

Efficacy of adding dexmedetomidine as adjuvant with bupivacaine in ultrasound-guided erector spinae plane block for post thoracotomy pain: Randomized controlled study Dexmedetomidine as adjuvant in ESPB for PTP

open access: yesEgyptian Journal of Anaesthesia, 2021
Background Poor management of postoperative pain results in physiological and psychological side effects with higher morbidity. Erector spinae plane block (ESPB) has shown efficacy in controlling pain in many surgeries.
Mamdouh Mahmoud Elshal   +4 more
doaj   +1 more source

Efficacy of perioperative duloxetine as a part of multimodal analgesia in laparoscopic colorectal cancer surgeries

open access: yesBMC Anesthesiology, 2023
Background Although laparoscopic surgery provides earlier recovery, less morbidity and hospital stay, however, severe pain is still a problem after it. Duloxetine has been recently used in postoperative pain management. We tested perioperative duloxetine
Diab Fuad Hetta   +5 more
doaj   +1 more source

Current Perspectives on Spinal Cord Stimulation for the Treatment of Cancer Pain

open access: yesJournal of Pain Research, 2020
Cancer and cancer treatment-related chronic pain affect a significant number of patients. The etiology of this pain is diverse and may include nociceptive and/or neuropathic characteristics.
J. Hagedorn   +4 more
semanticscholar   +1 more source

Cancer, cancer pain and the ‘Cancer Pain Initiative’

open access: yesAnaesthesia, Pain & Intensive Care, 2021
The number of cancer patients has been steadily increasing and with it the number of cancer related pain patients is also increasing. Cancer pain (CP) is the most unique and versatile pain, regarding type, intensity, site, variations and the needed management modalities.
openaire   +2 more sources

Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition) [PDF]

open access: yesZhongguo aizheng zazhi
Oxaliplatin serves as a basic therapeutic agent for various malignant tumors. Oxaliplatin-induced hypersensitivity reactions are potentially life-threatening, and frequently lead to treatment discontinuation.
Cancer Assessment Society of China Anti-Cancer Association, Cancer Pain Society of Fujian Anti-Cancer Association
doaj   +1 more source

Home - About - Disclaimer - Privacy